Cell line development and bioreactor process optimization for an atezolizumab biosimilar.
Kuyucu AZ, Sayili D, Orkut R, Mert O, Tarman İO, Lulaci B, Sencer AM, Pekmezci AK, Avci ME, Kalyoncu S, Inan M.
Kuyucu AZ, et al. Among authors: avci me.
Biotechnol Appl Biochem. 2024 Dec 2. doi: 10.1002/bab.2704. Online ahead of print.
Biotechnol Appl Biochem. 2024.
PMID: 39623595